Royal Philips (NYSE: PHG, AEX: PHIA) announces the first European installation of its new Allura Centron interventional X-ray (iXR) system - at the Clinique Pasteur in Toulouse, France. The Allura Centron system is designed for cardiac and electrophysiology procedures but can also be used effectively in neurological and vascular procedures. As part of the well-known Allura family of systems, it builds on proven technology to offer excellent image quality, ease of use and a familiar workflow. Moreover, it is a solution that enables high patient throughput, since it allows hospitals to carry out more routine procedures.
Globally, aging population and rising levels of obesity and diabetes make cardiovascular disease a growing burden (World Health Organization 'Cardiovascular diseases (CVDs)' fact sheet, March 2013). Coronary catheterization has become a routine procedure for treating cardiovascular diseases and is increasingly performed in hospitals around the world. However, in the current economic climate, resources for healthcare may be limited and under pressure. Allura Centron helps hospitals meet these challenges since it allows a wide range of high volume routine interventions on a single system. This allows hospitals to recover their investment efficiently.
This latest addition to the renowned Philips Allura X-ray systems shares much of the same technology, ensuring excellent image quality and performance, such as the MRC X-ray tube and high-performance 100 kW generator. In addition, the Allura Centron features a brand-new, next-generation 15" flat-panel X-ray detector, enabling easy support of a variety of minimally invasive applications. Allura Centron also uses the same user interface as the Philips Allura X-ray systems, enabling an enhanced workflow and ease of use.
"Installing the Allura Centron has really boosted the clinical offering and levels of care we can provide patients. It has increased the number of routine procedures we can perform daily, and freed up our existing Allura systems for more complex interventions. As it shares a common user interface and geometry with other Allura models, our operators have found it very easy to incorporate the Allura Centron into their existing workflows," says Dr. Daniel Colombier, Clinique Pasteur.
"Our vision to transform minimal invasive interventions is all about making a difference where it really matters," says Ronald Tabaksblat, General Manager iXR at Philips. "There is a growing need for a high quality interventional x-ray system which can handle a variety of routine procedures at high volume. The Allura Centron provides the answer, it's a highly flexible and efficient solution that delivers clinical and economic value where it is needed most - at the point of care."
The Allura Centron is available now in Asia, Europe, Africa and Latin America.
- Philips Healthcare's Profile
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 115,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.